Acadia Pharmaceuticals | ACAD - Ebit

股票价格

21.96

每天变化

-0.15 -0.68%

每月一次

-0.23%

每年

49.08%

Q2 预测

21.49

金融业

USD

USD 1.56B

现金及等价物

USD 819.69M

USD 26.23M

USD 1.06B

USD 277.11M

USD 54.81M

USD 17.39M

USD 35.76M

653

EPS每股收益

USD 1.6

股本和储备

USD 917.27M

USD 257.76M

债务利息支出

USD 0

USD 8.25M

USD 0

USD 3.63B

USD 273.57M

USD 266.6M

USD 17.39M

普通股股本

USD 169.18M

11.61

USD 26.32M

USD 284M

销售和管理费用

USD 146.73M

USD 34.67M

贸易债权人

USD 10.9M

应收帐款人

USD 148.23M

	Ebit	更改		日
Acadia Pharmaceuticals	USD 17.39M		18.36M	2025-12
ALKERMES	USD -10.95M		100.03M	2025-12
Alnylam Pharmaceuticals	USD 29.4M		59.36M	2025-12
Biogen	USD 659.6M		157M	2025-09
BioMarin Pharmaceutical	USD 198.39M		230.08M	2025-12
Bristol-Myers Squibb	USD 3.47B		567M	2025-12
Cara Therapeutics	USD -5.94M		3.55M	2025-09
Corcept Therapeutics	USD 4.49M		5.73M	2025-12
Cytokinetics	USD -178.37M		11.61M	2025-12
Eisai	JPY 20.03B		6.36B	2025-12
Eli Lilly	USD 8.99B		1.57B	2025-12
Incyte	USD 383.88M		47.44M	2025-12
J&J	USD 6.62B		1.51B	2026-03
Moderna	USD -857M		597M	2025-12
Neurocrine Biosciences	USD 227.9M		11.4M	2025-12
Pfizer	USD 4.65B		71M	2025-12
Prothena	USD -27.21M		12.55M	2025-12
PTC Therapeutics	USD -81.62M		85.11M	2025-12
Sarepta Therapeutics	USD -410.08M		347.2M	2025-12
Ultragenyx Pharmaceutical	USD -114M		56.89M	2025-12
Vanda Pharmaceuticals	USD -10.28M		721K	2024-12
Vertex Pharmaceuticals	USD 1.26B		24.5M	2025-12